<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC4420971/results/search/funders/results.xml">
  <result pre="Faculty of Medicine School of Public Health and Community Medicine," exact="University of New South Wales" post="Sydney Australia [2], National Institute of Hygiene and Epidemiology"/>
  <result pre="Institute for Clinical Pathology and Medical Research, Westmead Hospital and" exact="University of Sydney" post="Sydney, New South Wales Australia [4], Beijing Centers for"/>
  <result pre="University of Sydney Sydney, New South Wales Australia [4], Beijing" exact="Centers for Disease Control and Prevention" post="Beijing China Correspondence to Professor C Raina MacIntyre; r.macintyre@unsw.edu.au"/>
  <result pre="for assessment of all particulate filters for respiratory protection. The" exact="3M" post="9320 N95 and 3M Vflex 9105 N95 were used"/>
  <result pre="particulate filters for respiratory protection. The 3M 9320 N95 and" exact="3M" post="Vflex 9105 N95 were used to compare against the"/>
  <result pre="(97%) compared with medical masks (44%) (used in trial) and" exact="3M" post="9320 N95 (&amp;lt;0.01%), 3M Vflex 9105 N95 (0.1%). Discussion"/>
  <result pre="masks (44%) (used in trial) and 3M 9320 N95 (&amp;lt;0.01%)," exact="3M" post="Vflex 9105 N95 (0.1%). Discussion We have provided the"/>
  <result pre="Hanoi hospitals who participated. They also acknowledge the support of" exact="3M" post="for testing of filtration of the facemasks. 3M was"/>
  <result pre="support of 3M for testing of filtration of the facemasks." exact="3M" post="was industry partner in the ARC linkage project grant;"/>
  <result pre="not involved in study design, data collection or analysis. The" exact="3M" post="products were not used in this study. Contributors: CRM"/>
  <result pre="Funding: Funding to conduct this study was received from the" exact="Australian Research Council" post="(ARC) (grant number LP0990749). Competing interests: CRM has held"/>
  <result pre="(ARC) (grant number LP0990749). Competing interests: CRM has held an" exact="Australian Research Council" post="Linkage Grant with 3M as the industry partner, for"/>
  <result pre="CRM has held an Australian Research Council Linkage Grant with" exact="3M" post="as the industry partner, for investigator-driven research. 3M has"/>
  <result pre="Grant with 3M as the industry partner, for investigator-driven research." exact="3M" post="has also contributed masks and respirators for investigator-driven clinical"/>
  <result pre="has also received funding from vaccine manufacturers GSK, bio-CSL and" exact="Sanofi" post="Pasteur for investigator-driven research and presentations. AAC used filtration"/>
  <result pre="filtration testing of masks for his PhD thesis conducted by" exact="3M" post="Australia. Ethics approval: National Institute for Hygiene and Epidemiology"/>
  <result pre="05 IRB) and the Human Research Ethics Committee of the" exact="University of New South Wales" post="(UNSW), Australia, (HREC approval number 10306). Provenance and peer"/>
  <result pre="statement: No additional data are available. References References 1 collab:" exact="World Health Organization" post="(WHO). Global Alert and Response (GAR), Pandemic (H1N1) 2009—update"/>
  <result pre="(H1N1) 2009—update 76 (cited 27 Apr 2012). http://www.who.int/csr/don/2009_11_27a/en/index.html 2 collab:" exact="World Health Organization" post="(WHO). Human infection with avian influenza A(H7N9) virus—update ("/>
  <result pre="Infect Dis 2013; 17: e143– 4. 10.1016/j.ijid.2012.12.001 23270612 5 collab:" exact="World Health Organization" post="(WHO). Global Alert and Response (GAR). Ebola virus disease"/>
  <result pre="Development of Reusable Facemasks for Use During an Influenza Pandemic." exact="National Academy of Sciences" post=", 2006. 35 collab: Center for Disease Control and"/>
  <result pre="2006. 35 collab: Center for Disease Control and Prevention and" exact="World Health Organization." post="Infection control for viral haemorrhagic fevers in the African"/>
  <result pre="viral haemorrhagic fevers in the African health care setting. Atlanta:" exact="Centers for Disease Control and Prevention," post="1998: 1– 198. 36 collab: World Health Organization (WHO)."/>
  <result pre="for Disease Control and Prevention, 1998: 1– 198. 36 collab:" exact="World Health Organization" post="(WHO). Guidelines for the prevention of tuberculosis in health"/>
 </snippets>
</snippetsTree>
